HTS for enhancers of neutrophil function that specifically augment PIP3 signal
HTS for enhancers of neutrophil function that specifically augment PIP3 signal
批准号:
7651612
负责人:
Hongbo R Luo
金额:
$38.18万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-06 至 2013-01-31
关键词:
BacteriaBindingBiologicalBiological AssayCalcium SignalingCell LineCell membraneCellsCellular biologyCessation of lifeChemicalsChemistryChemotactic FactorsChemotaxisCytoplasmCytosolDataDevelopmentEnhancersEvaluationEventFundingFutureGenetic ScreeningGoalsGreen Fluorescent ProteinsGuidelinesHL-60 CellsHomologous GeneHost DefenseImmuneInfectionInstitutesInvadedLeadLeukocytesLifeMediatingMembraneMethodsNIH Program AnnouncementsNatural ImmunityPH DomainPathway interactionsPhagocytosisPhosphatidylinositolsPhosphorylationPreclinical Drug EvaluationProcessProductionProtein translocationReproducibilityResearchScreening procedureSignal TransductionSuperoxidesSystemWritingassay developmentbasecell typechemical geneticsdrug developmenthigh throughput screeningin vivokillingsmedical schoolsmicroorganismneutrophilnovelpathogenphosphatidylinositol 3,4,5-triphosphateplatelet protein P47public health relevanceresearch studysmall moleculesmall molecule libraries
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neutrophils are the most abundant cell type among circulating white cells and constitute the first line of host defense against invading pathogens. Various neutrophil functions such as chemotaxis, phagocytosis, superoxide production, death/survival, and bacteria killing, can be regulated by PtdIns(3,4,5)P3, an inositol phospholipid localized on the plasma membrane. PtdIns(3,4,5)P3 exerts its function by mediating protein translocation via binding to their pleckstrin homolog (PH)-domains. Thus, PH domain translocation provides an attractive target for developing modulators of neutrophil function. The ultimate goal of this study is to identify PtdIns(3,4,5)P3 pathway activators that specifically target PH domain plasma membrane translocation via conducting a high throughput chemical genetic screening. We have recently established an experimental system for visualizing this process in live cells. We utilized the PH-domain of Akt (PHAkt) fused with green fluorescent protein (PHAkt-GFP) as a marker for this event. A HL60 cell line stably expressing PHAkt-GFP has been generated. HL60 cells can be induced to differentiate towards morphologically mature neutrophils. PHAkt-GFP translocation from cytosol to the plasma membrane could be easily detected in differentiated HL60 cells after chemoattractant stimulation. While PHAkt-GFP translocates to the leading edge of chemotaxing cells in chemotactic gradient, during uniform treatment with chemoattractant it transiently translocates from cytosol to the plasma membrane. Elevating PtdIns(3,4,5)P3 signal not only augments the initial cytoplasm-to-plasma membrane translocation of PHAkt-GFP, but also dramatically delays its subsequent "reverse translocation" from the plasma membrane to cytosol, providing an excellent readout for high throughput screening (HTS). A method for quantifying PHAkt-GFP plasma membrane translocation has also been established. In addition, our preliminary data demonstrated the selectivity and reproducibility of our assay for detecting chemoattractant- elicited PH domain membrane translocation. In this proposed research, we will adapt this cell-based system to a high-throughput format and examine whether the same selectivity and reproducibility can be achieved (Aim I). In addition, several secondary screening assays will be established to confirm the effect of each positive hit compound identified from the primary screening and to identify the most specific and potent ones for future characterization (Aim II). Finally, a plan to evaluate the biological activities of identified compounds is proposed. We will investigate whether elevating PH domain membrane translocation by identified compounds is able to enhance various neutrophil functions (Aim III). PUBLIC HEALTH RELEVANCE: Project Narrative The ultimate goal of our research is to identify PtdIns(3,4,5)P3 pathway activators that specifically target PH domain plasma membrane translocation via performing a high throughput screening of small molecule libraries. Discovery of these activators will greatly facilitate our research on PtdIns(3,4,5)P3 signaling in neutrophil function and innate immunity. Moreover, the identified activators can be directly utilized as starting chemical compounds for novel immune enhancer drug development, particularly for severe infections due to lack of enough pathogen killing capability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Strategies to Improve Blood Transfusion Practice
-
批准号:10494380
-
项目类别:
-
资助金额:$265.54万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Novel Strategies to Improve Blood Transfusion Practice
-
批准号:10682582
-
项目类别:
-
资助金额:$259.02万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Improving granulocyte transfusion in neutropenia-related infections
-
批准号:10494384
-
项目类别:
-
资助金额:$68.15万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Administrative Core
-
批准号:10494381
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Administrative Core
-
批准号:10682583
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Improving granulocyte transfusion in neutropenia-related infections
-
批准号:10682602
-
项目类别:
-
资助金额:$66.47万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10229487
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10687091
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:9894354
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation
-
批准号:10405596
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation
-
批准号:10620756
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation
-
批准号:10194356
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10460992
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10021397
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Cell-based high-throughput chemical genetic screening for GSDMD inhibitors
-
批准号:10317059
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil function by ROS-induced actin glutathionylation
-
批准号:8811096
-
项目类别:
-
资助金额:$44.1万
-
财政年份:2014
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil function by ROS-induced actin glutathionylation
-
批准号:9014505
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2014
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil function by ROS-induced actin glutathionylation
-
批准号:8629271
-
项目类别:
-
资助金额:$43.85万
-
财政年份:2014
-
负责人:Hongbo R Luo
-
依托单位:
Cell signaling in granulocyte transfusion
-
批准号:9294152
-
项目类别:
-
资助金额:$44.57万
-
财政年份:2010
-
负责人:Hongbo R Luo
-
依托单位:
Cell signaling in granulocyte transfusion
-
批准号:7798884
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2009
-
负责人:Hongbo R Luo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: